课题基金 / 基金详情

Biochemical analysis of the novel tumor suppressor gene product RECK

Biochemical analysis of the novel tumor suppressor gene product RECK
新型抑癌基因产物RECK的生化分析
批准号:
08660101
负责人:
MAKI Masatoshi
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

MAKI Masatoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
RECK is a novel tumor suppressor gene which reverses normally the activated-ras-transformed mouse fibroblast cells. In malignant transformed cells, its expression is suppressed. Forced exogenous expression of the gene in the cancer cells suppresses colony formation in soft agar and inhibits tumor metastasis. We characterized the gene product as follows :(1) Partial cDNA was expressed in E.coli, and the purified recombinant protein was subjected to immunize mice for preparation of monoclonal antibodies. Hybridomas were screened with ELISA method. (2) RECK cDNA was expressed in insect cells using baculovirus system. Western analysis using the monoclonal antibodies revealed that the molecular mass of the expressed protein was about 100 kDa. It agreed well with the value estimated from the amino acid sequence and suggested low glycosylation. (3) RECK contains signal sequence at N-terminus and hydrophobic sequence at C-terminus and is transported onto the membrane outside of the cell. Deletion of the C-terminal hydrophobic region caused secretion of RECK into the culture medium. We established a method of affinity purification of the secreted type of RECK by substituting the C-terminal sequence with a tag of histidine hexamer. (4) Potential reactive site residue (P1) of the Kazal domain of RECK is Asp and it suggests caspase-like proteases as target enzymes. RECK did not inhibit caspase-1. It did not interact with granzyme B,either.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
中脇修二その他4名: "新規がん抑制タンパク質RECKに対するモノクローナル抗体の作製" 農芸化学会誌. 71・臨時増刊. 277 (1997)
Shuji Nakawaki 等 4 人:“针对新型肿瘤抑制蛋白 RECK 的单克隆抗体的制备”,日本农业化学学会杂志 71/特刊 277(1997 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Chiaki Takahashi et al.: "Suppression of invasion and metastasis of tumor cells by RECK gene product" SEIKAGAKU. vol.68-No.7. 1073 (1996)
Chiaki Takahashi 等:“RECK 基因产物抑制肿瘤细胞的侵袭和转移”SEIKAGAKU。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
高橋智聡その他4名: "RECK遺伝子産物による腫瘍細胞の浸潤・転移の抑制について" 生化学. 68・7. 1073 (1996)
高桥智明等4人:《RECK基因产物对肿瘤细胞侵袭和转移的抑制》《生物化学》68・7(1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
中脇 修二、その他4名: "新規ガン抑制タンパク質RECKに対するモノクローナル抗体の作製" 農芸化学会誌. 71臨時増刊. 277 (1997)
Shuji Nakawaki 等 4 人:“针对新型癌症抑制蛋白 RECK 的单克隆抗体的制备”,《农业化学学会杂志》71 号特刊(1997 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
6
    Elucidation of physiological functions of the EF-hand protein ALG-2 as a calcium-stress response factor
    • 批准号:
      17H03803
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2017
    • 负责人:
      MAKI Masatoshi
    • 依托单位:
    Regulatory mechanism of adipocyte differentiation by PLSCR3 mediated by extracellularly secreted vesicle exosomes
    • 批准号:
      25660076
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      MAKI Masatoshi
    • 依托单位:
    Roles of calcium-dependent adaptor protein ALG-2 in regulation of intracellular delivery system
    • 批准号:
      23380056
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.15万
    • 财政年份:
      2011
    • 负责人:
      MAKI Masatoshi
    • 依托单位:
    Analysis of calcium-dependent adaptor function of apoptosis-associated protein ALG-2
    • 批准号:
      20380059
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2008
    • 负责人:
      MAKI Masatoshi
    • 依托单位:
    国内基金
    海外基金
    内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
    • 批准号:
      82371317
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      万杰清
    • 依托单位:
    新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
    • 批准号:
      82371711
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      吕志宝
    • 依托单位:
    抑素蛋白(prohibitin)1调控蛋白酶激活受体(protease-activated receptor)1内化转运及降解的功能和机制
    三角帆蚌丝氨酸蛋白酶(serine protease)基因的克隆、表达调控与功能研究
    • 批准号:
      31040083
    • 项目类别:
      专项基金项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2010
    • 负责人:
      肖调义
    • 依托单位: